Liver transplantation for alcoholic liver disease: Lessons learned and unresolved issues.

08:00 EDT 21st October 2015 | BioPortfolio

Summary of "Liver transplantation for alcoholic liver disease: Lessons learned and unresolved issues."

The use of liver transplantation (LT) as a treatment for alcoholic liver disease (ALD) has been highly controversial since the beginning. The ever increasing shortage of organs has accentuated the low priority given to patients suffering from ALD, which is considered a "self-inflicted" condition. However, by improving the long-term survival rates, making them similar to those from other indications, and recognizing that alcoholism is a primary disease, ALD has become one of the most common indications for LT in Europe and North America, a situation thought unfathomable thirty years ago. Unfortunately, there are still many issues with the use of this procedure for ALD. There are significant relapse rates, and the consequences of excessive drinking after LT range from asymptomatic biochemical and histological abnormalities to graft failure and death. A minimum three-month period of sobriety is required for an improvement in liver function, thus making LT unnecessary, and to demonstrate the patient's commitment to the project, even though a longer abstinence period does not guarantee lower relapse rates after LT. Recent data have shown that LT is also effective for severe alcoholic hepatitis when the patient is unresponsive to corticosteroids therapy, with low relapse rates in highly selected patients, although these results must be confirmed before LT becomes a standard procedure in this setting. Finally, LT for ALD is accompanied by an increased risk of de novo solid organ cancer, skin cancer, and lymphoproliferative disorders, which has a large impact on the survival rates.


Journal Details

This article was published in the following journal.

Name: World journal of gastroenterology
ISSN: 2219-2840
Pages: 10994-1002


DeepDyve research library

PubMed Articles [20873 Associated PubMed Articles listed on BioPortfolio]

Temporal Trends Associated with the Rise in Alcoholic Liver Disease Related Liver Transplantation in the United States.

In the United States, alcoholic liver disease (ALD) has recently become the leading indication for liver transplantation (LT).

Differing Impact of Sarcopenia and Frailty in Non-Alcoholic Steatohepatitis (NASH) and Alcoholic Liver Disease (ALD).

Sarcopenia and frailty are commonly encountered in patients with end stage liver disease and are associated with adverse clinical outcomes including decompensation and waitlist mortality. The impact o...

Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation: many unanswered questions.

Post transplant non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) is very common. The progression of fibrosis is accelerated in these patients as compared to NASH in ge...

Transplantation for Alcoholic Hepatitis: Are We Achieving Justice and Utility?

Early liver transplantation (LT) is an emerging therapy for acute severe alcoholic hepatitis (AH) in fact recent data show that alcoholic-liver disease is the predominant driver of cirrhosis-related m...

Liver transplantation for severe alcoholic hepatitis: where are we now?

Although a minority of patients with alcohol-related liver disease (ALD) meet the rigorous criteria for acceptance, liver transplantation (LT) activity for ALD has continued to increase [1]. Timing of...

Clinical Trials [9861 Associated Clinical Trials listed on BioPortfolio]

Role of CCL2 in Alcoholic Liver Diseases

Immune dysregulations, including cytokines and chemokines secretions occurs in alcoholic liver disease. Serum levels and liver expression of CCL2 are increased in patients with alcoholic h...

Quantifying Steatosis in Liver Transplant Donors

Non-alcoholic fatty liver disease is the most common chronic liver disease in Hong Kong. Its presence among donors of living donor liver transplants could affect the outcomes of recipients...

Effect of Non-alcoholic Fatty Liver Disease on Kidney Functions

Non-alcoholic fatty liver disease is the most common cause of chronic liver disease worldwide. It is defined as the accumulation of fat (>5%) in the liver cells in the absence of excessive...

Herbal Supplements for Improvement of Liver Function in Participants With Alcoholic Liver Disease

Alcoholic liver disease represents the major health issues and it ranges from simple steatosis to cirrhosis. There is a paucity of data to support the allopathic intervention among these g...

Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant Recipients

The purpose of this study is is to use non-invasive diagnostic tests, Fibroscan and a simple blood test, to diagnose NASH in patients who undergo liver transplantation. Liver transplantati...

Medical and Biotech [MESH] Definitions

Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS.

Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.

Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Lipid infiltration of the hepatic parenchymal cells that is due to ALCOHOL ABUSE. The fatty changes in the alcoholic fatty liver may be reversible, depending on the amounts of TRIGLYCERIDES accumulated.

Conditions in which the LIVER functions fall below the normal ranges. Severe hepatic insufficiency may cause LIVER FAILURE or DEATH. Treatment may include LIVER TRANSPLANTATION.

Quick Search


DeepDyve research library

Relevant Topic

Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Searches Linking to this Article